Taro Pharmaceutical
TARO
#5055
Rank
NZ$2.79 B
Marketcap
NZ$74.38
Share price
0.00%
Change (1 day)
9.34%
Change (1 year)

Taro Pharmaceutical (TARO) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : NZ$0.66 Billion

According to Taro Pharmaceutical's latest financial reports the company's total liabilities are NZ$0.66 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Taro Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-03-31NZ$0.64 B-3.63%
2022-03-31NZ$0.67 B-34.18%
2021-03-31NZ$1.01 B161.89%
2020-03-31NZ$0.38 B18.39%
2019-03-31NZ$0.32 B6.7%
2018-03-31NZ$0.30 B0.01%
2017-03-31NZ$0.30 B-15.06%
2016-03-31NZ$0.36 B-15.75%
2015-03-31NZ$0.43 B41.53%
2014-03-31NZ$0.30 B18.07%
2013-03-31NZ$0.25 B
2011-12-31NZ$0.28 B29.24%
2010-12-31NZ$0.22 B-42.23%
2009-12-31NZ$0.38 B-27.52%
2008-12-31NZ$0.53 B23.51%
2007-12-31NZ$0.43 B-19.02%
2006-12-31NZ$0.53 B-13.43%
2005-12-31NZ$0.61 B33.71%
2004-12-31NZ$0.45 B11.75%
2003-12-31NZ$0.41 B96.53%
2002-12-31NZ$0.20 B-1.92%
2001-12-31NZ$0.21 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$200.16 B 30,006.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$134.39 B 20,113.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$196.53 B 29,460.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$56.43 B 8,388.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$106.08 B 15,855.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$108.25 B 16,182.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland